Status:
UNKNOWN
Cardiac Imaging in SARS-CoV-2 (COVID-19)
Lead Sponsor:
NHS Greater Glasgow and Clyde
Collaborating Sponsors:
University of Glasgow
Conditions:
COVID
Eligibility:
All Genders
18+ years
Brief Summary
One-in-four patients with COVID-19 pneumonia develop life-threatening heart problems. Through cardiovascular imaging and biomarkers analyses this study aims to evaluate whether COVID-19 infection resu...
Detailed Description
Our study is supported through the Chief Scientist Office Rapid Research in Covid-19 (RARC-19) programme. Our study will clarify the pathogenesis of cardiopulmonary injury, notably endotypes of myocar...
Eligibility Criteria
Inclusion
- History of hospital attendance or hospitalisation for COVID-19, confirmed by a clinical diagnosis, laboratory test e.g. PCR and/or a radiological test e.g. CT chest or chest X-ray
- Age 18 years or more
- Capacity to provide written informed consent
- Able to comply with study procedures
Exclusion
- Contra-indication to CMR e.g. severe claustrophobia, metallic foreign body
- Lack of informed consent
- Women who are pregnant, breast-feeding or of child-bearing potential without a negative pregnancy test
Key Trial Info
Start Date :
May 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04403607
Start Date
May 22 2020
End Date
May 1 2023
Last Update
March 3 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Alexandra Hospital
Paisley, Renfrewshire, United Kingdom, PA2 9PJ
2
Royal Infirmary
Glasgow, United Kingdom, G31 2ER
3
Queen Elizabeth University Hospital
Glasgow, United Kingdom, G51 4TF